1. Home
  2. GKOS vs PHI Comparison

GKOS vs PHI Comparison

Compare GKOS & PHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GKOS
  • PHI
  • Stock Information
  • Founded
  • GKOS 1998
  • PHI 1928
  • Country
  • GKOS United States
  • PHI Philippines
  • Employees
  • GKOS N/A
  • PHI N/A
  • Industry
  • GKOS Medical/Dental Instruments
  • PHI Telecommunications Equipment
  • Sector
  • GKOS Health Care
  • PHI Telecommunications
  • Exchange
  • GKOS Nasdaq
  • PHI Nasdaq
  • Market Cap
  • GKOS 5.8B
  • PHI 5.0B
  • IPO Year
  • GKOS 2015
  • PHI 1953
  • Fundamental
  • Price
  • GKOS $89.83
  • PHI $22.81
  • Analyst Decision
  • GKOS Strong Buy
  • PHI
  • Analyst Count
  • GKOS 12
  • PHI 0
  • Target Price
  • GKOS $131.17
  • PHI N/A
  • AVG Volume (30 Days)
  • GKOS 1.2M
  • PHI 60.9K
  • Earning Date
  • GKOS 07-30-2025
  • PHI 08-22-2025
  • Dividend Yield
  • GKOS N/A
  • PHI 5.46%
  • EPS Growth
  • GKOS N/A
  • PHI 20.57
  • EPS
  • GKOS N/A
  • PHI 2.62
  • Revenue
  • GKOS $432,953,000.00
  • PHI $3,879,170,293.00
  • Revenue This Year
  • GKOS $27.88
  • PHI $3.36
  • Revenue Next Year
  • GKOS $27.76
  • PHI $2.58
  • P/E Ratio
  • GKOS N/A
  • PHI $8.55
  • Revenue Growth
  • GKOS 26.70
  • PHI 2.02
  • 52 Week Low
  • GKOS $77.10
  • PHI $20.29
  • 52 Week High
  • GKOS $163.71
  • PHI $29.05
  • Technical
  • Relative Strength Index (RSI)
  • GKOS 43.89
  • PHI 50.65
  • Support Level
  • GKOS $88.94
  • PHI $22.55
  • Resistance Level
  • GKOS $92.70
  • PHI $23.43
  • Average True Range (ATR)
  • GKOS 3.82
  • PHI 0.36
  • MACD
  • GKOS 0.38
  • PHI -0.07
  • Stochastic Oscillator
  • GKOS 46.71
  • PHI 28.57

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

About PHI PLDT Inc. Sponsored ADR

PLDT Inc is the telecommunications carrier in the Philippines. The company's business activities include three business units: Wireless, Fixed Line and Others. The wireless segment consists of mobile telecommunications services provided by Smart and DMPI, and Fixed-line telecommunications services mainly provided by PLDT. It also provides fixed-line services through PLDT's subsidiaries.

Share on Social Networks: